Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor  by Nishimura, Hiroyuki et al.
Immunity, Vol. 11, 141±151, August, 1999, Copyright 1999 by Cell Press
Development of Lupus-like Autoimmune Diseases
by Disruption of the PD-1 Gene Encoding
an ITIM Motif-Carrying Immunoreceptor
(reviewed by Miller and Flavell, 1994). Similar, if less
tight, self-tolerance mechanisms are also considered to
operate in B cells (reviewed by Goodnow et al., 1995).
Systemic lupus erythematosus (SLE), a prototype of
human systemic autoimmune diseases, is characterized
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murine models that spontaneously develop lupus-likeEhime, 791-0295
diseases have been extensively studied for decades.Japan
NZB, MRL/Mp, and BXSB mice develop lupus-like dis-
eases of rather late onset with a similar yet distinct
disease spectrum (reviewed by Theofilopoulos andSummary
Dixon, 1985). NZBxNZW F1 (reviewed by Drake et al.,
1995), MRL/Mp-lpr/lpr (reviewed by Cohen and Eisen-PD-1, a 55 kDa transmembrane protein containing an
berg, 1991), and BXSB/Yaa (reviewed by Izui et al., 1995),immunoreceptor tyrosine-based inhibitory motif, is in-
which are generated by the introduction of additionalduced in lymphocytes and monocytic cells following
genetic factors into the above model mice, develop byactivation. Aged C57BL/6(B6)-PD-12/2 congenic mice
far more aggressive diseases of earlier onset. Recentspontaneously developed characteristic lupus-like pro-
genome-wide linkage analysis of these lupus-proneliferative arthritis and glomerulonephritis with pre-
mice has revealed a number of loci linked with the indi-dominant IgG3 deposition, which were markedly ac-
vidual disease manifestations, although none of thesecelerated by introduction of a Fas mutation (lpr).
susceptible genes have been identified to date (re-Introduction of a PD-1 null mutation into the 2C-TCR
viewed by Vyse and Kotzin, 1998).(anti-H-2Ld) transgenic mice of the H-2b/d background
Under such circumstances, genetically manipulatedresulted in the chronic and systemic graft-versus-
murine models that develop various aspects of lupus-host-like disease. Furthermore, CD812C-TCR1PD-12/2
like disease would be quite helpful in providing insightsT cells exhibited markedly augmented proliferation in
into the pathogenesis of lupus. Although the overex-vitro in response to H-2d allogenic cells. Collectively,
pression of the bcl-2 (Strasser et al., 1991) or fli (Zhangit is suggested that PD-1 is involved in the maintenance
et al., 1995) oncogene was reported to develop glomeru-of peripheral self-tolerance by serving as a negative
lonephritis, these transgenic mouse models may notregulator of immune responses.
be suitable for elucidation of etiological mechanisms of
natural autoimmune diseases because this pathogene-
Introduction sis is primarily due to proliferation and/or survival of
lymphocytes expressing the transgenes rather than to
Self-tolerance is maintained in distinct immunocompe- specific defects in the immune regulation. Glomerulone-
tent cells at different stages (reviewed by Mondino et phritis but not arthritis was also reported in lyn-deficient
al., 1996). In T cells, for instance, autoreactive T cell mice (Hibbs et al., 1995; Nishizumi et al., 1995). Unlike
clones can be clonally eliminated in the thymus during the natural lupus-prone mice and human SLE patients
the differentiation process (negative selection or cen- that produce elevated levels of IgG, however, lyn-defi-
tral tolerance) (Kappler et al., 1987; reviewed by von cient mice exhibit a rather selective increase in IgM. So
Boehmer, 1990, 1991; Nossal, 1994). T cells that have far, none of the known genes have been shown to be
managed to escape from negative selection and are responsible for both glomerulonephritis and arthritis, the
released in the periphery are still constrained to avoid hallmarks of systemic autoimmune diseases.
response to autoantigens (peripheral tolerance) (re- The PD-1 gene, which belongs to the immunoglobulin
viewed by Miller and Morahan, 1992; Mondino et al., gene superfamily, encodes a 55 kDa type I transmem-
1996). Several distinct mechanisms for peripheral toler- brane protein (Agata et al., 1996) containing the immu-
ance have been proposed based upon various animal noreceptor tyrosine-based inhibitory motif (ITIM), V/Ix-
models, including clonal anergy, downregulation of YxxL, (reviewed by Thomas, 1995; Vivier and Daeron,
antigen receptor/coreceptor complex (Rocha and von 1997) in its cytoplasmic tail. The structure of PD-1 in-
Boehmer, 1991), and involvement of active suppression cluding the ITIM motif is conserved between mouse
and human (Shinohara et al., 1994; Finger et al., 1997).
Although PD-1 is expressed only on a tiny population‖To whom correspondence should be addressed (e-mail: honjo@
mfour.med.kyoto-u.ac.jp). in the thymus of normal mice, it has been found to be
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Table 1. Frequency of Autoimmune Diseases in B6-PD-12/2 and B6-lpr/lpr 3 PD-12/2 Mice
Genotype B6 B6-PD-12/2 B6 B6-PD-12/2 B6-lpr/lpr B6-lpr/lpr 3 B6-lpr/lpr 3 MRL-lpr/lpr
PD-11/2 PD-12/2
Age (month) 6 6 14 14 6 6 6 6
Glomerulonephritis
Grade 0 5 7 0 0 10 0 0 0
Grade 1 0 3 4 2 4 6 1 2
Grade 2 0 0 0 2 1 1 8 2
Grade 3 0 0 0 0 0 1 0 3
Arthritis
Grade 0 5 6 4 0 15 5 1 1
Grade 1 0 4 0 2 0 2 2 0
Grade 2 0 0 0 1 0 1 5 4
Grade 3 0 0 0 1 0 0 1 2
Total animals examined 5 10 4 4 15 8 9 7
Numbers of animals showing indicated grades of glomerulonephritis or arthritis at the age of 6 or 14 months. Glomerulonephritis was classified
into four grades: grade 0, no remarkable change; grade 1, segmental mesangial proliferation and cell infiltration with less than 50% of glomeruli
affected; grade 2, global mesangial proliferation and cell infiltration with more than 50% of glomeruli affected; grade 3, crescent formation.
Arthritis grading was as follows: grade 0, no remarkable change; grade 1, increased lining layers; grade 2, granulomatous inflammation
involving subsynovial lining tissues; grade 3, pannus formation. U tests of Mann-Whitney are as follows: in glomerulonephritis, p 5 0.2482
between B6 and B6-PD-12/2 mice at 14 months of age, and p 5 0.003 between B6-lpr/lpr and B6-lpr/lpr 3 PD-12/2 mice at 6 months of age;
in arthritis, p 5 0.02 between B6 and B6-PD-12/2 mice at 14 months of age, and p 5 0.003 between B6-lpr/lpr and B6-lpr/lpr 3 PD-12/2 mice
at 6 months of age.
induced strongly in the peripheral lymphocytes of both Results
T and B lineages, thus being classified as an activation
antigen (Agata et al., 1996; Nishimura et al., 1996). PD- Spontaneous Development of Lupus-like Diseases
1-deficient mice exhibited mild yet consistent spleno- in Aged B6-PD-12/2 Mice
megaly and selective augmentation in IgG3 antibody PD-12/2 mice were backcrossed 11 generations with B6
response to a TI-2 antigen. Splenic B cells from PD-1- mice (B6-PD-12/2 mice), and their organs were examined
deficient mice also responded more vigorously to anti- histologically. At 6 months of age, three out of ten B6-
IgM stimulation in vitro (Nishimura et al., 1998). These PD-12/2 mice exhibited mild proliferative glomerulone-
results have implied that PD-1 might be involved in the phritis with less than 50% of glomeruli affected (grade
negative regulation of certain immune responses in vivo. 1), and four out of ten exhibited arthritis with increased
Recently, a number of receptors that bear the ITIM motif lining layers of synovial tissues in foot joints (grade 1)
have been reported (reviewed by Burshtyn and Long, (see Table 1 legend). In B6 mice at this age, such histo-
1997), among which CD22, FcgRIIB, and killer cell inhibi- logical changes were not observed at all. Significant
tory receptors (KIRs) were most extensively studied deposition of IgG3 was detected in glomeruli of B6-
(Doody et al., 1995; Pani et al., 1995; Vivier and Daeron, PD-12/2 mice along with C3 deposition, whereas little
1997). It is indicated that these proteins function as deposition of IgG was detected in those of B6 except
negative regulators for tyrosine kinase-based signaling for marginal IgG2a (Figure 1). Deposition of IgM could be
pathways of immunological receptors by recruiting tyro- detected in renal glomeruli of both B6 and B6-PD-12/2
sine phosphatases such as SHP-1 (Shen et al., 1991; mice irrespective of histological changes. Marked and
Matthews et al., 1992; Plutzky et al., 1992; Yi et al., 1992) selective increase in serum IgG3 was also noted in all
and inositol phosphatase, SHIP (Ono et al., 1996), via of B6-PD-12/2 mice at this age (data not shown).
ITIM motif. Mice deficient for CD22 and FcgRIIB were At 14 months of age, two out of four B6-PD-12/2 mice
indicated to show markedly augmented B cell responses exhibited typical lupus-like glomerulonephritis of grade
in vivo (O'Keefe et al., 1996; Otipoby et al., 1996; Sato 2, resembling endocapillary proliferative glomerulone-
et al., 1996; Takai et al., 1996). These mice, however, phritis, accompanied by deposition of PAS-positive ma-
terials (Figures 2B and 2C, see legend in detail), whilehave not been reported to develop any signs of systemic
autoimmune diseases. age-matched B6 mice showed mild glomerulonephritis
of grade 1, which was usually observed in such agedIn the present study, we report that PD-1-deficient B6
mice spontaneously developed typical lupus-like glo- mice (Table 1; Figure 2A). Histological changes of grade
2 or above indicate the overt pathological lesions dis-merulonephritis and destructive arthritis as they age,
both of which were markedly exaggerated by the intro- tinct from age-related changes, and the findings were
considered to be quite significant. Foot joints of all fourduction of the lpr/lpr mutation. Using a H-2Ld-specific
TCR-transgenic mouse model, we also showed that PD-1 B6-PD-12/2 mice showed histological evidence of arthri-
tis, and two of them exhibited many advanced arthriticdeficiency induced overt graft-versus-host-like disease
in the autoreactive genetic background and, further, that lesions of grade 2 to 3 with extensive granulomatous
inflammation (Figures 2E and 2F, see legend in detail).PD-1 functions as a negative regulator for the prolifera-
tion of primed T cell clones in response to the specific Control B6 mice never exhibited the histological evi-
dence for arthritis at the same age (Figure 2D; Table 1)H-2d target cells in vitro. Based on these results, we
propose that PD-1 deficiency provokes specific lupus- or even older (reviewed by Theofilopoulos and Dixon,
1985). These results indicate that the PD-1 gene defectlike diseases probably via chronic breakdown of periph-
eral self-tolerance in vivo. results in the development of chronically progressive
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Figure 1. Immunohistochemical Examination of Immunoglobulin Deposits in Renal Glomeruli from B6-PD-12/2 and B6-lpr/lpr 3 PD-12/2 Mice
Sections of kidneys from B6, B6-PD-12/2, B6-lpr/lpr, B6-lpr/lpr 3 PD-12/2, and MRL-lpr/lpr mice at 24±27 weeks of age were stained with goat
antisera to mouse IgM, IgG2a, IgG3, or complement C3. Representative pictures are shown.
lupus-like glomerulonephritis and arthritis of rather late was observed in any of the age-matched B6-lpr/lpr mice
(Figure 2J; Table 1). Thus, introduction of the lpr/lpronset in the B6 background.
mutation into B6-PD-12/2 mice was shown to accelerate
both onset and severity of glomerulonephritis and arthri-Acceleration and Augmentation of Lupus-like
Diseases in the B6-PD-12/2 Mice by tis to the extents similar to those in MRL-lpr/lpr mice
(Table 1). Since the lpr mutation alone hardly inducedIntroduction of the lpr Mutation
Manifestation of the chronic diseases in lupus-prone the glomerulonephritis and arthritis in B6 mice (reviewed
by Theofilopoulos and Dixon, 1985), this mutation ap-MRL mice of late onset is known to be markedly acceler-
ated by the introduction of the lpr mutation (reviewed by pears to accelerate the phenotypes of the PD-1 defi-
ciency. Indeed, B6-lpr/lpr 3 PD-11/- mice exhibited inter-Theofilopoulos and Dixon, 1985; Cohen and Eisenberg,
1991). We therefore generated B6-PD-12/2 3 lpr/lpr mice mediate grades of the diseases between B6-lpr/lpr and
B6-lpr/lpr 3 PD-12/2 mice (Table 1), suggesting that theto see whether the lpr/lpr mutation similarly affects the
development of the diseases in PD-1-deficient mice. PD-1 gene may have a dosage effect on the develop-
ment of lupus-like diseases.Eight out of nine B6-lpr/lpr 3 PD-12/2 mice at 6 months
of age developed typical glomerulonephritis (grade 2) B6-lpr/lpr 3 PD-12/2 mice also developed more exten-
sive lymphadenopathy than B6-lpr/lpr mice at 16 weeks(Figure 2H; Table 1, legend) with extensive immune com-
plex deposition as indicated by PAS staining (Figure 2I), of age (39.4 6 6.9 versus 475.7 6 171.2 mg, n 5 4, t ,
0.01, weight of the largest axillary lymph node), the ex-whereas only 1 out of 15 B6-lpr/lpr mice showed grade
2 lesions at the same age (Figure 2G; Table 1). Immuno- tent being even greater than those in MRL-lpr/lpr mice
(207.5 6 126.2 mg). Histologically, unusual presence offluorescence analysis of the kidney again revealed the
predominant deposition of IgG3 in glomeruli of B6-lpr/ mitotic figures was specifically noted in lymph nodes of
B6-lpr/lpr 3 PD-12/2 mice (Figure 2O) along with exten-lpr 3 PD-12/2 mice, while little IgG3 deposition was de-
tected in B6-lpr/lpr mice with marginal IgG2a (Figure sive hyperplasia of the bone marrow (Figures 2M and
2N). Flow cytometric analysis revealed that the propor-1). Deposition of C3 was by far more abundant in the
glomeruli of B6-lpr/lpr 3 PD-12/2 mice than in those of tion of ªabnormalº B2201Thy11 T cells in the lymph
nodes of B6-lpr/lpr 3 PD-12/2 mice was markedly in-B6-lpr/lpr mice. MRL-lpr/lpr mice exhibited the abun-
dant glomerular deposition of both IgG subclasses (Fig- creased as compared with those in B6-lpr/lpr mice
(65.1% versus 39.3%) (Figure 3A, upper panel) and wasure 1), conforming to the previous reports (Izui et al.,
1984; Slack et al., 1984). again comparable with that in MRL-lpr/lpr mice (65.6%).
The fraction of CD42CD82 T cells was calculated by sub-Histology of foot joints also revealed advanced ar-
thritic lesions (grade 2±3) in six out of nine B6-lpr/lpr 3 tracting the fractions of CD41 and CD81 cells (Figure 3A,
lower panel) from those of the total Thy-11 cells: 30.9%,PD-12/2 mice at 6 months of age (Figures 2K and 2L;
Table 1, legend). No histological evidence for arthritis 60.5% and 61.1% in B6-lpr/lpr, B6-lpr/lpr 3 PD-12/2,
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Figure 2. Histology of Various Tissues from
B6-PD-12/2 and B6-lpr/lpr 3 PD-12/2 Mice
Representative pictures of various organs
from B6 (A and D) and B6-PD-12/2 mice (B,
C, E, and F) at 14 months of age and B6-lpr/
lpr (G, J, and M) and B6-lpr/lpr 3 PD-12/2
mice (H, I, K, L, N, and O) at 24±27 weeks
of age are shown; (A)±(C) and (G)±(I), kidney;
(D)±(F) and (J)±(L), foot joints; (M) and (N),
bone marrow; and (O), lymph node. All pic-
tures are H-E staining except that (C) and (I)
are PAS staining pictures. Original magnifica-
tions are as follows: (A)±(C), (F), (G)±(I), and
(L), 3100; (D), (E), (J), and (K), 325; (M) and
(N), 350; (O), 3200. Glomeruli of B6-PD-12/2
mice at 14 months of age were enlarged and
lobulated with increased cellularity associ-
ated with marked inflammatory cell infiltration
with hyaline droplet deposition in mesangium
and hyaline thrombi in capillary lumen (B) ac-
companied by deposition of PAS-positive
materials along the capillary wall and in mes-
angium (C). Foot joints of B6-PD-12/2 mice
were accompanied with proliferation of syno-
vial lining layers, inflammatory cell infiltration,
and granulomatous lesions in the sublining
region (grade 2) (E), which extended into bone
matrices with pannus formation accompa-
nied by osteoclast infiltration (grade 3) (F).
Similar trends mentioned above were ob-
served in kidney (H and I) and foot joints (K
and L) of B6-lpr/lpr 3 PD-12/2 mice at 24±27
weeks of age.
and MRL-lpr/lpr mice, respectively. Considering by far T cells are potentially autoreactive (Sha et al., 1988a).
B6-PD-12/2 mice were backcrossed two to four genera-greater cellularity in the lymph nodes of B6-lpr/lpr 3
PD-12/2 mice as compared with B6-lpr/lpr mice, the tions with BALB/c mice to generate PD-11/2 (H-2d/d)
mice, which were then crossed with 2C 3 PD-12/2 (H-2b/b)increase in the number of abnormal T cells by the PD-1
deficiency in the B6-lpr/lpr mice was extraordinary. mice, giving rise to 2C 3 PD-12/2 (H-2b/d) mice. Among 69
2C 3 PD-12/2H-2b/d mice, 17 mice appeared moribundThe difference between B2201Thy-11 T cells and
CD42CD82 T cells could be explained by B2201CD41 and/or died by the age of 10 weeks, and the rest showed
significant growth retardation (22.0 6 3.8 versus 31.1 6T cells (Asano et al., 1988; Kariyone et al., 1988), because
the majority of not only CD42CD82 but also CD41 T 3.7 g, t , 5 3 1026) and splenomegaly (284.3 6 141.4
versus 113.9 6 26.6 mg, t , 0.0005) as compared withcells, but not CD81 T cells, expressed PD-1 in B6-lpr/
lpr mice (Figure 3B). Since the majority of abnormal T 2C 3 PD-11/1 mice. By 10 weeks of age, 23 out of 69
2C 3 PD-12/2 H-2b/d mice showed various degrees ofcells in the lymph nodes of B6-lpr/lpr mice expressed
other activation markers such as CD44 and CD69 (Figure skin lesions, such as dermatitis-like lesions, necrotic
lesions, and erythema (data not shown), which were3B), the results implied that PD-1 on these abnormal T
cells might serve as a negative regulator for their expan- accompanied by inflammatory cell infiltration into epi-
dermis typically seen in the graft-versus-host diseasesion. CD41CD81 cells are occasionally encountered in
the B6-lpr/lpr mice irrespective of PD-1 deficiency (Fig- (Figures 4A±4C, see legend in detail). Many other organs
including heart (Figures 4E and 4F), lung (Figures 4Hures 3A and 3B), the nature of which remains unknown.
and 4I), liver (Figure 4J), salivary glands (Figure 4K),
pancreas (Figure 4L), and kidney (data not shown)Evidence for the Activation of 2C-TCR Transgenic
T Cells in the Autoreactive Background were also found to be infiltrated densely with inflamma-
tory cells. Immunohistochemical analysis revealed thatIn Vivo in the Absence of PD-1
Since the observations described above have implied CD81 and 2C-TCR1 T cells were infiltrated into the basal
layer of the epidermis in 2C 3 PD-12/2 (Figures 4N andthat the PD-1 deficiency might have resulted in the
chronic breakdown of self-tolerance, we wished to di- 4P) but not in 2C 3 PD-11/1 mice (Figures 4M and 4O).
All these features are compatible with the chronic graft-rectly examine the effect of PD-1 deficiency on poten-
tially autoreactive T cells in vivo. For this purpose, H-2Ld- versus-host disease. All of 59 2C 3 PD-11/1H-2b/d mice
appeared healthy and showed no overt evidence of dis-reactive 2C-TCR transgenic mice in the H-2b/d back-
ground were employed, in which the transgenic CD81 eases (Figures 4A, 4D, and 4G).
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Figure 3. Flow Cytometric Analysis of Lymph
Node Cells from B6-lpr/lpr 3 PD-12/2 Mice
(A) Lymph node cells from B6-lpr/lpr, B6-lpr/
lpr 3 PD-12/2, and MRL-lpr/lpr mice at 6
months of age were stained with anti-B220
and anti-Thy-1 or with anti-CD4 and CD8
mAbs. Numbers indicate percentages in
gated regions. (B) Lymph node cells from B6-
lpr/lpr mice at 16 weeks of age were exam-
ined for the expression of indicated antigens.
In upper panels, the expression of CD4/CD8
or PD-1/TCRb, CD25, CD69, or CD44 was
shown in contour plots. In lower panels, the
expression of PD-1 or TCRb on CD42CD82,
CD41CD82, CD42CD81 subsets was shown
in histograms. Bold lines represent control
staining.
In 2C H-2b/d transgenic mice, the vast majority of versus 1.35 6 0.81 3 106, n 5 16, t , 0.0005), most of
which indeed expressed 2C-TCR (Figures 5B and 5C).CD41CD81 thymocytes expressing 2C-TCR were nega-
tively selected in the thymus, and thus only negligible A significant proportion of the minute CD81 T cell popu-
lation in the 2C H-2b/d mice expressed PD-1, while noneCD81 T cells appeared in the spleen as reported pre-
viously (Sha et al., 1988a) (Figures 5A and 5B). The ab- in the 2C 3 PD-12/2 H-2b/d mice did so as expected.
We further compared the surface phenotypes of splenicsence of PD-1 did not appear to affect the negative
selection or rather accelerated the process, if any (Fig- CD81 T cells in 2C H-2b/d and 2C 3 PD-12/2 H-2b/d mice.
There was a significant increase in the CD45RBlowure 5A). Indeed, as compared with control 2C H-2b/d
mice, the total numbers of thymocytes were reduced CD62LlowCD691 population in 2C 3PD-12/2 H-2b/d mice as
compared with 2C H-2b/d mice (Figure 5C). The meanby one-third on average in 2C 3 PD-12/2 H-2b/d mice
(9.79 6 3.67 versus 3.25 6 1.09 3 106, t , 0.005), in intensity of CD44 expression was higher in 2C 3PD-
12/2 H-2b/d mice, while CD25 was not detected in eitherwhich the reduction of the CD41CD81 population was
much more extensive (37.7 6 23.9 versus 5.75 6 4.21 3 type of mice. These results indicate that a considerable
proportion of the peripheral CD81 T cells in 2C 3 PD-104, t , 0.05), while the CD41CD82 population without
2C-TCR expression was affected marginally if at all (84.1 6 12/2 H-2b/d mice exhibited the so-called ªantigen-primedº
phenotype. The results collectively suggested that there38.7 3 104 versus 120.4 6 93.5 3 104, t 5 0.4). In
contrast, the total cell number in the spleens of 2C 3 was significant activation and proliferation of autoreac-
tive CD812C-TCR1 T cells in the periphery of 2C 3PD-PD-12/2 H-2b/d mice were significantly increased as com-
pared with those in 2C H-2b/d mice (2.51 6 0.61 versus 12/2 H-2b/d mice in spite of the fact that negative selection
of 2C-TCR1 thymocytes occurred even more efficiently1.01 6 0.28 3 107, n 5 16, t , 5 3 1027). More notably,
there was much greater accumulation of CD81 T cells than in 2C H-2b/d mice, thereby giving rise to the systemic
graft-versus-host-like disease.in the spleens of the former than the latter (6.19 6 4.51
Immunity
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Figure 4. Histology of Various Tissues from
2C 3 PD-12/2 (H-2b/d) Mice at 10 Weeks of
Age
The representative pictures of H-E staining
of skin lesions (A±C), hearts (D±F), lungs (G±I),
liver (J), salivary gland (K), and pancreas (L)
are shown. Sections from skin lesions were
stained with anti-mouse CD8a (M and N) or
anti-mouse 2C TCR (1B2) mAb (O and P).
Arrows indicate DAB-positive cells in (N) and
(P) panels. Pictures (A), (D), (G), (M), and (O)
are from control 2C mice, and others are from
2C 3 PD-12/2 (H-2b/d) mice. The original mag-
nifications are as follows: (D), (E), (G), and (H),
310; (A), (B), (J), (K), and (L), 325; (F), (I), and
(M±P), 350; (C), 3100. In the skin lesions of
2C 3 PD-12/2 (H-2b/d) mice, hyperkeratosis,
hypergranulosis, and acanthosis were ob-
served as well as the dense inflammatory cell
infiltration in the dermis associated with sub-
epidermal clefts (liquefaction degeneration)
(C) and destruction of skin appendage (B) typi-
cally seen in graft-versus-host disease as com-
pared with that of control 2C (H-2b/d) mice (A).
Augmented Proliferation of CD812C-TCR1 T Cells (Figures 6B and 6C). By contrast, 2C-TCR1PD-12/2 T
cells showed a markedly augmented proliferative re-in Response to the Specific Antigen
in the Absence of PD-1 sponse specifically against BALB/c splenocytes (H-2d)
but not against B6 splenocytes (H-2b) as comparedFinally, to gain an insight into the molecular mechanisms
for the functions of PD-1 in T cells, we directly compared with 2C-TCR1PD-11/1 T cells (Figure 6D). The results
strongly suggest that PD-1 on the primed T cells nega-the proliferative response of the 2C-TCR1 T cells in the
presence and absence of PD-1. For this particular pur- tively regulates the TCR-mediated proliferative re-
sponse by the stimulation with specific antigen-present-pose, spleen cells from B6-2C and B6-2C 3 PD-12/2
mice were used, in which 2C-TCR1 T cells were consid- ing cells.
ered to be positively selected in a normal fashion (Sha
et al., 1988a), because the number of those in H-2b/d Discussion
background was too small to be directly examined.
Since PD-1 is an activation-induced antigen (Agata et al., In the present study, we have shown that B6-PD-12/2
mice chronically develop lupus-like proliferative glomer-1996), spleen cells prestimulated in vitro with BALB/c
splenocytes have been examined. After the prior stimu- ulonephritis and arthritis by 14 months of age, while B6-
PD-11/1 mice at this age developed marginal, probablylation in vitro, essentially all blastic cells of both B6-
2C and B6-2C 3 PD-12/2 mice expressed CD8 and the age-related glomerular lesions and no evidence of arthri-
tis. B6-PD-12/2 mice exhibited deposition of IgG, selec-clonotypic (2C) TCR at comparable levels, while PD-1
was expressed only on the 2C-TCR1 T cells from B6- tively of the IgG3 subclass, and abundant C3 comple-
ment in renal glomeruli, strongly suggesting that the2C mice as expected (Figure 6A). When these cells were
stimulated with either IL-2 or anti-CD3 monoclonal anti- glomerulonephritis was immune-complex mediated. The
arthritis, on the other hand, histologically resembledbody, 2C-TCR1 and 2C-TCR1PD-12/2 cells exhibited
comparable proliferative responses, indicating that the the rheumatoid arthritis characterized by the extensive
proliferation of synovial cells, dense inflammatory cellcell autonomous proliferation via TCR or the IL-2 recep-
tor per se was not affected by the absence of PD-1 infiltration, and pannus formation. The homozygous lpr
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Figure 5. Flow Cytometric Analyses of Thymocytes and Splenocytes from 2C 3 PD-11/1 and 2C 3 PD-12/2 Mice in H-2b/d Autoreactive Condition
Total thymocytes (A) and splenocytes (B) were examined for the expression of CD4 and CD8. The numbers in quadrates indicate percentages
of gated regions. 2C-TCR expression was examined for CD41 cells. (C) The expression of indicated antigens was examined in CD8 compart-
ments gated as shown in (B). The numbers indicate percentages in gated regions of each histogram. The upper (1/1) and lower (2/2) panels
denote 2C 3 PD-11/1 and 2C 3 PD-12/2 mice, respectively. The representative data are shown. The numbers indicate percentages of gated
regions.
mutation of the Fas gene in lupus-prone MRL/Mp mice autoreactive genetic background. In the control 2C
H-2b/d transgenic mice, the vast majority of thymocytesis well known to exaggerate the lupus-like multiorgan
diseases as well as lymphadenopathy (reviewed by were deleted at the CD41CD81 stage, and accordingly
there were very few CD42CD81 T cells in the spleenTheofilopoulos and Dixon, 1985; Cohen and Eisenberg,
1991). Such effects, however, largely depend on the (1.35 6 0.81 3 106 cells). Such a minute number of
CD812C-TCR1 T cells mostly exhibited the naive T cellbackground genes of mice (reviewed by Theofilopoulos
and Dixon, 1985), and, thus, the same Fas mutation phenotype (CD45RBhigh CD62Lhigh without CD69 activa-
tion marker). In PD-12/2 3 2C H-2b/d mice, thymic nega-hardly results in the development of lupus-like diseases
in B6 or C3H mice except for lymphadenopathy (re- tive selection of CD81 cells appeared to take place even
more efficiently, leading to the accelerated reduction inviewed by Cohen and Eisenberg, 1991), strongly sug-
gesting that the lpr mutation functions as an accelerat- total as well as CD41CD81 thymocytes as compared
with 2C H-2b/d mice (Figure 5A). In the spleen of PD-12/2 3ing factor for some of the lupus-prone genetic traits in
MRL/Mp mice. Our present results have shown that the 2C H-2b/d mice, however, a significant increase in the
CD812C-TCR1 T cells was noted (6.19 6 4.51 3 106manifestation of both glomerulonephritis and arthritis in
B6-PD-12/2 mice is also greatly accelerated in terms cells). Furthermore, a significant fraction of these
CD812C-TCR1 T cells exhibited the so-called memoryof the disease onset and severity by the additional lpr
mutation. Other organ involvement such as vasculitis phenotype (CD45RBlowCD62Llow as well as CD69 expres-
sion), strongly implying that they had been primed toand sialoadenitis frequently seen in MRL-lpr/lpr mice
was not observed. These results indicate that the PD-1 the ªselfº H-2Ld antigen in vivo. The assumption has
been strongly reinforced by the observation that moregene deficiency predisposes to the development of pro-
liferative glomerulonephritis and arthritis, the two major than half of PD-12/2 3 2C H-2b/d mice developed multior-
gan lesions histologically compatible with the graft-ver-lesions in the systemic lupus disease.
To explore the possibility that the PD-1 deficiency sus-host disease within 10 weeks of age, while PD-11/1 3
2C H-2b/d transgenic mice remained totally healthy. Itmight result in the breakdown of certain aspects of self-
tolerance at the clonal level of T cells in vivo, we have was confirmed that CD812C-TCR1 T cells indeed infil-
trated into the basal layer of the detached epidermis,generated PD-12/2 3 2C H-2b/d mice in the potentially
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Figure 6. Proliferative Responses of 2C-
TCR1CD81 T Cells from B6-2C and 2C 3
PD-12/2 Mice
(A) Flow cytometric analysis of 2C-TCR1 T
cells expanded by coculturing with BALB/c
(H-2d/d) splenocytes. 2C-TCR1 T cells from 2C 3
PD-11/1 (upper panels) or 2C 3 PD-12/2
(lower panels) mice were analyzed for the ex-
pression of indicated antigens on the sur-
face. (B±D) Thymidine incorporation assay.
2C1CD81 T cells from 2C 3 PD-11/1 (open
rectangles) and 2C 3 PD-12/2 (open circles)
mice were stimulated with indicated units of
IL-2 (B) or concentration of anti-CD3e (C).
2C1CD81 T cells from 2C 3 PD-11/1 (rectan-
gles) or 2C 3 PD-12/2 (circles) mice were
stimulated with indicated numbers of mito-
mycin C±treated splenocytes from B6 (open
symbols) and BALB/c (closed symbols) mice
(D). Bars indicate standard deviations. These
experiments were performed in triplicate.
which is pathognomonic for the graft-versus-host skin It is tempting to speculate that such autoreactive T cell
clones ªseeº the antigen and are ªactivatedº at leastlesion (Volc Platzer et al., 1988; Kawai et al., 1991; Mur-
phy et al., 1991). Thus, these results strongly suggest partially although further expansion is restricted by PD-1.
On the other hand, the lpr/lpr mutation results in thethat the potentially autoreactive T cells in the periphery
can be functionally activated, leading to the overt patho- peripheral accumulation of T cells with the unusual phe-
notype. Present results have indicated that these T cellsgenesis in the absence of PD-1. Possible involvement
of the CD41 helper T cells in the activation of CD812C- express PD-1 along with other activation markers (Fig-
ure 3B). Although their origin remains obscure, these TTCR clones in this particular system remains to be eluci-
dated. Selective elimination of the CD4 population in cells in the lymph nodes are nondividing resting cells
that are destined to be eliminated but have survivedvivo in the PD-12/2 3 2C H-2b/d mice by injection of anti-
CD4 antibodies may answer this question. apoptosis in the absence of Fas (reviewed by Nagata
and Golstein, 1995). In mice with the double mutationAlthough exact molecular functions of PD-1 remain
to be investigated, it is noted that PD-1 bears the ITIM of Fas and PD-1, the number of these abnormal T cells
in the lymph nodes was markedly increased, and, moremotif (Ishida et al., 1992), which is shared by a series of
immunological negative receptors including CD22 and notably, mitotic figures were frequently seen (Figure 2O).
The results suggest a scenario in which the abnormalFcgRIIB on B cells and KIRs on NK cells (Doody et al.,
1995; Pani et al., 1995; reviewed by Vivier and Daeron, T cells might expand in the absence of PD-1 and survive
by escaping from apoptosis in the additional defect of1997). In the present study, we indicated that the PD-
12/2CD812C-TCR1 T cells normally developed in the Fas. Although it remains to be seen whether or not these
T cells represent autoreactive clones, the synergisticH-2b background exhibited by far greater specific prolif-
erative response against the H-2d target cells than PD- effect of PD-1 deficiency on abnormal T cell expansion
with the lpr mutation might fit with the above assumption11/1CD812C-TCR1 T cells. In contrast, PD-12/2CD812C-
TCR1 T cells showed comparable proliferative response that PD-1 is involved in the negative regulation of clonal
expansion and possibly even acceleration of activation-with PD-11/1CD812C-TCR1 T cells to the anti-CD3 anti-
body or to IL-2, suggesting that the effect of PD-1 was induced cell death following antigen stimulation.
Development of lupus glomerulonephritis is believednot T cell autonomous. These results have implied that
PD-1 negatively regulate antigen-stimulated T cell re- to be initiated by the deposition of autoantibodies. It
has also been indicated that the presence of autoanti-sponse by interacting with a certain ligand expressed
on the antigen-presenting cells. PD-1 is hardly ex- bodies is not necessarily sufficient, but particular fea-
tures of the antibodies such as specific isotypes and/pressed on resting lymphocytes but is strongly induced
following the activation, unlike other ITIM-containing re- or cationicity are required for the pathogenicity (Datta et
al., 1987; Takahashi et al., 1991). Present results indicateceptors mentioned above (Agata et al., 1996). Thus, it
is likely that the negative effect of PD-1 is manifested that there is rather selective deposition of the IgG3 sub-
class along with C3 in the glomeruli of B6-PD-12/2 miceat the later stage of lymphocyte activation to restrict
the progression of the response, clonal expansion for in agreement with the previous report indicating the
selective increase in serum IgG3 as well as augmentedinstance, rather than to inhibit the initiation. In this as-
pect, it is noted that a good fraction of a minute number IgG3 production in response to a TI-2 antigen in the B6-
PD-12/2 mice (Nishimura et al., 1998). A crucial role ofof the splenic CD812C-TCR1 T cells in the 2C transgenic
mice of H-2b/d did express PD-1 despite the fact that autoantibodies of the IgG3 subclass for the pathogene-
sis of glomerulonephritis has been reported in murinethey largely exhibited the naive phenotype (Figure 5C).
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models: MRL-lpr/lpr mice were shown to exhibit a pref- response. Indeed, our unpublished results indicate that
erential increase in IgG3 in either immune complex or the primary monocytes from PD-12/2 mice show much
self-aggregate form as they aged not only in the serum greater response to GM-CSF or M-CSF than those from
but also in the elutes of affected kidneys (Slack et al., normal mice, which is consistent with the significant
1984; Takahashi et al., 1991). Also, administration of myeloid cell hyperplasia in the spleen (Nishimura et al.,
IgG3 monoclonal antibodies derived thereof was shown 1998) and bone marrow (Figure 2N) of the B6-PD-12/2
to be capable of inducing lupus nephritis in normal mice and B6-PD-12/2 3 lpr/lpr mice, respectively. Thus, in
(Takahashi et al., 1993). On the contrary, introduction of addition to the underlying breakdown of self-tolerance
the xid mutation or CD40L null mutation into MRL-lpr/ in T cells, the dysregulated activation of inflammatory
lpr mice, which results in the reduced serum IgG3 level cells may well contribute to the development of prolifera-
(Perlmutter et al., 1979) and abrogated antibody re- tive and destructive arthritis.
sponse against TI-2 antigens (Scher et al., 1975a, Recent genome-wide linkage analysis has revealed
1975b), has been reported to suppress the development that a number of multiple genes are involved in a wide
of lupus nephritis (Steinberg et al., 1983; Ma et al., 1996). variety of distinct pathological manifestations in the lu-
Taken together, we speculate that the development of pus disease (reviewed by Vyse and Kotzin, 1998). Our
autoantibodies of the IgG3 subclass in the absence of present results have indicated clearly that the defect in
PD-1 is crucially involved in the pathogenesis of glomer- the single PD-1 gene specifically predisposes to the
ulonephritis, although the nature of autoantigens for development of both glomerulonephritis and arthritis of
IgG3 is unknown. Unlike most of the lupus-prone mice, the lupus type. Furthermore, the manifestation of dis-
common autoantibodies represented by anti-double eases in the absence of PD-1 appears to be related to
strand DNA (dsDNA) and rheumatoid factor (RF) were the background genes, because BALB/c-PD-12/2 mice
hardly detected in B6-PD-12/2 mice (unpublished data). developed lethal pancarditis with massive thrombosis,
Anti-dsDNA, however, was detected in around 50% of which is also seen rather frequently in human SLE, with-
B6-lpr/lpr and in the vast majority of B6-PD-12/2 3 lpr/ out glomerulonephritis and arthritis (unpublished data).
lpr and MRL-lpr/lpr mice at much higher titers. Most The results suggest that the pathogenic effects of PD-1
notably, anti-dsDNA antibodies in sera of B6-PD-12/2 3 deficiency depend on the complex interaction with yet
lpr/lpr mice were mostly of the IgG2a subclass, and undefined background genes, which may determine the
IgG3 anti-dsDNA antibodies were undetectable, making ultimate manifestation of the disease target. The human
the pathogenic contribution of anti-dsDNA antibodies PD-1 locus has been mapped at chromosome 2q.37.3
to the glomerulonephritis rather unlikely in the present (Shinohara et al., 1994; Finger et al., 1997), which has
model. Most recently, the mice deficient for CD22, a not been so far linked to human autoimmune diseases.
typical ITIM-based negative regulator on B cells, were Further genetic as well as functional analyses of human
reported to develop high-titer anti-dsDNA antibodies of PD-1, however, may provide new insights into the patho-
IgG2a as they aged with no evidence of pathogenesis genesis of the complex lupus-like diseases.
(O'Keefe et al., 1999). At present, mechanisms for the
selective effects of PD-1 deficiency on the IgG3 sub-
Experimental Proceduresclass remain to be investigated. It could be due either
to the cell autonomous dysfunction of B cells producing Mice
IgG3, to the secondary B cell dysregulation by PD-1- B6, BALB/c, B6-pr/lpr, and MRL-lpr/lpr mice were purchased from
deficient T cells, or both. SLC (Shizuoka, Japan). PD-12/2 mice (Nishimura et al., 1998) were
backcrossed 11 generations with B6 mice (B6-PD-12/2 mice). TheseProliferative and sometimes destructive arthritis is an-
mice were maintained in our specific pathogen-free facility at theother hallmark for the human systemic autoimmune dis-
Institute of Laboratory Animals, Faculty of Medicine, Kyoto Univer-eases. Among naturally occurring lupus-prone model
sity, Japan. 2C-TCR transgenic mice (Sha et al., 1988b), which weremice, only MRL mice are known to develop such arthri-
a kind gift from D. Loh, were backcrossed six generations both with
tis, which is markedly accelerated by the introduction B6 and B6-PD-12/2 mice. Because the 2C transgene insertional locus
of the lpr/lpr mutation (reviewed by Theofilopoulos and was found to be linked with the PD-1 gene locus by around 10±15
Dixon, 1985). B6-PD-12/2 mice, which develop arthritis cM, we generated three lines having the two genes in the same
chromosomes (2C 3 PD-11/-H-2b/b mice). To obtain the H-2d allele,with histologically indistinguishable characteristics from
B6-PD-12/2 mice were backcrossed two to four generations withthose in MRL mice as well as human rheumatoid arthri-
BALB/c mice (H-2d-PD-11/2 mice). 2C and 2C 3 PD-11/2 mice (H-2b/b)tis, provide a rare instance to our knowledge that a
mice were crossed with BALB/c and H-2d-PD-11/2 mice, respec-known single gene mutation results in the lupus-like
tively, to generate 2C 3 PD-11/1 and 2/2 mice of the (H-2b/d) back-
arthritis. The arthritis in B6-PD-12/2 mice has been also ground in negative selective condition.
markedly accelerated by the additional introduction of
the lpr/lpr mutation. Considering the distinct histological Histological and Immunohistochemical Examinations
features, it seems rather unlikely that the glomerulone- Indicated tissues were fixed with 10% formalin in phosphate-buf-
phritis and arthritis develop by the same pathogenic fered saline (PBS) and embedded in paraffin. Sections were stained
mechanisms. In this aspect, it should be noted that with hematoxylin and eosin or periodic acid-Schiff (PAS) by standard
methods. For immunofluorescence studies of deposition of immu-PD-1 is expressed not only on T cells but also on B cells
noglobulins, kidneys were embedded in OCT compound (Miles) and(Agata et al., 1996) as well as macrophages following
snap frozen. 4±5 mm sections were air-dried and fixed with coldactivation (unpublished data). Based on the present re-
acetone. These cryosections were pretreated with goat serum and
sults in the 2C-TCR H-2b/d transgenic mouse model, it stained with biotinylated goat antisera F(ab9)2 against IgM, IgG2a,
would be reasonable to assume that PD-1 induced on IgG3, or C3 complement (Southern Biotechnology) as primary anti-
the other types of cells might also be involved in negative bodies, followed by incubation with streptoavidin (SA)-fluorescein
isothiocyanate (FITC) (DAKO, A/S, Denmark). For immunochemistry,regulation of various effector functions in the immune
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cryosections were pretreated with 2% BSA in PBS/0.05% Tween (1995). Genetic contributions to lupus-like disease in (NZB 3
NZW)F1 mice. Immunol. Rev. 144, 51±74.(PBS/T) for 30 min and incubated with biotinylated CD8a or 1B2
overnight. After washing twice with PBS/T, sections were incubated Finger, L.R., Pu, J., Wasserman, R., Vibhakar, R., Louie, E., Hardy,
with avidin and biotinylated-HRP (VECTASTAIN ABC kit, Vector Lab- R.R., Burrows, P.D., and Billips, L.G. (1997). The human PD-1 gene:
oratory) and developed with 0.02% H2O2 and diaminobenzidine tet- complete cDNA, genomic organization, and developmentally regu-
rahydrochloride (DAB) (Wako, Osaka, Japan) according to the pro- lated expression in B cell progenitors. Gene 197, 177±187.
cedures of the manufacturer. The sections were counterstained with Goodnow, C.C., Cyster, J.G., Hartley, S.B., Bell, S.E., Cooke, M.P.,
hematoxylin by standard methods. Healy, J.I., Akkaraju, S., Rathmell, J.C., Pogue, S.L., and Shokat,
K.P. (1995). Self-tolerance checkpoints in B lymphocyte develop-
Flow Cytometric Analysis ment. Adv. Immunol. 59, 279±368.
The following antibodies were purchased from PharMingen: FITC- Hibbs, M.L., Tarlinton, D.M., Armes, J., Grail, D., Hodgson, G., Mag-
labeled anti-mouse CD8a (53-6.7), phycoerythrin-R (PE)-conjugated litto, R., Stacker, S.A., and Dunn, A.R. (1995). Multiple defects in the
anti-CD4 (RM4-5), FITC-labeled anti-mouse Thy-1 (30-H12), PE-con- immune system of Lyn-deficient mice, culminating in autoimmune
jugated anti-mouse CD45R/B220 (RA3-6B2), biotinylated anti- disease. Cell 83, 301±311.
mouse CD25 (7D4), biotinylated anti-mouse CD44(1M7), biotinylated
Ishida, Y., Agata, Y., Shibahara, K., and Honjo, T. (1992). Inducedanti-mouse CD45RB (16A), biotinylated anti-mouse CD62L (MEL-
expression of PD-1, a novel member of the immunoglobulin gene14), and biotinylated anti-mouse CD69 (H1.2F3). Anti-2C TCRab
superfamily, upon programmed cell death. EMBO J. 11, 3887±3895.clonotypic mAb, 1B2 (Kranz et al., 1984), and anti-mouse PD-1 mAb
Izui, S., Kelley, V.E., Masuda, K., Yoshida, H., Roths, J.B., and Mur-(J43) were biotinylated. Cells were preincubated with 2.4G2 (anti-
phy, E.D. (1984). Induction of various autoantibodies by mutant geneFc receptor mAb) and then stained with the indicated antibodies,
lpr in several strains of mice. J. Immunol. 133, 227±233.followed by flow cytometric analysis.
Izui, S., Iwamoto, M., Fossati, L., Merino, R., Takahashi, S., and
Ibnou Zekri, N. (1995). The Yaa gene model of systemic lupus erythe-Proliferative Assay
matosus. Immunol. Rev. 144, 137±156.Splenocytes from 2C and 2C 3 PD-12/2 mice on the H-2b/b back-
ground were stimulated with mitomycin C (Sigma Chemical)±treated Kappler, J.W., Roehm, N., and Marrack, P. (1987). T cell tolerance
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